Cargando…

Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes

BACKGROUND: Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment before elec...

Descripción completa

Detalles Bibliográficos
Autores principales: Namula, Zhao, Hirata, Maki, Le, Quynh Anh, Lin, Qingyi, Takebayashi, Koki, Yoshimura, Naoaki, Tanihara, Fuminori, Thongkittidilok, Chommanart, Otoi, Takeshige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788957/
https://www.ncbi.nlm.nih.gov/pubmed/34674375
http://dx.doi.org/10.1002/vms3.659
_version_ 1784639660872433664
author Namula, Zhao
Hirata, Maki
Le, Quynh Anh
Lin, Qingyi
Takebayashi, Koki
Yoshimura, Naoaki
Tanihara, Fuminori
Thongkittidilok, Chommanart
Otoi, Takeshige
author_facet Namula, Zhao
Hirata, Maki
Le, Quynh Anh
Lin, Qingyi
Takebayashi, Koki
Yoshimura, Naoaki
Tanihara, Fuminori
Thongkittidilok, Chommanart
Otoi, Takeshige
author_sort Namula, Zhao
collection PubMed
description BACKGROUND: Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment before electroporation on embryonic development and gene editing in porcine embryos were evaluated. METHODS: The ZP of zygotes was weakened or removed by exposure to 0.5% actinase E, followed by electroporation of the Cas9 protein with guide RNA targeting GGTA1. RESULTS: The blastocyst formation rate of ZP‐free zygotes after electroporation was significantly lower (p < 0.05) than that of ZP‐intact zygotes. The mutation rate in blastocysts from ZP‐weakened zygotes was similar to that in ZP‐intact zygotes, whereas ZP removal increased the mutation rate. The mutation efficiency in blastocysts from electroporated zygotes did not differ among ZP treatment groups. CONCLUSIONS: Our results indicate that weakening the ZP does not affect the developmental competence, mutation rate, or mutation efficiency of electroporated zygotes, whereas ZP removal has a detrimental effect on embryonic development but may increase the mutation rate.
format Online
Article
Text
id pubmed-8788957
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87889572022-02-01 Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes Namula, Zhao Hirata, Maki Le, Quynh Anh Lin, Qingyi Takebayashi, Koki Yoshimura, Naoaki Tanihara, Fuminori Thongkittidilok, Chommanart Otoi, Takeshige Vet Med Sci PIGS BACKGROUND: Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment before electroporation on embryonic development and gene editing in porcine embryos were evaluated. METHODS: The ZP of zygotes was weakened or removed by exposure to 0.5% actinase E, followed by electroporation of the Cas9 protein with guide RNA targeting GGTA1. RESULTS: The blastocyst formation rate of ZP‐free zygotes after electroporation was significantly lower (p < 0.05) than that of ZP‐intact zygotes. The mutation rate in blastocysts from ZP‐weakened zygotes was similar to that in ZP‐intact zygotes, whereas ZP removal increased the mutation rate. The mutation efficiency in blastocysts from electroporated zygotes did not differ among ZP treatment groups. CONCLUSIONS: Our results indicate that weakening the ZP does not affect the developmental competence, mutation rate, or mutation efficiency of electroporated zygotes, whereas ZP removal has a detrimental effect on embryonic development but may increase the mutation rate. John Wiley and Sons Inc. 2021-10-21 /pmc/articles/PMC8788957/ /pubmed/34674375 http://dx.doi.org/10.1002/vms3.659 Text en © 2021 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle PIGS
Namula, Zhao
Hirata, Maki
Le, Quynh Anh
Lin, Qingyi
Takebayashi, Koki
Yoshimura, Naoaki
Tanihara, Fuminori
Thongkittidilok, Chommanart
Otoi, Takeshige
Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_full Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_fullStr Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_full_unstemmed Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_short Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_sort zona pellucida treatment before crispr/cas9‐mediated genome editing of porcine zygotes
topic PIGS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788957/
https://www.ncbi.nlm.nih.gov/pubmed/34674375
http://dx.doi.org/10.1002/vms3.659
work_keys_str_mv AT namulazhao zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT hiratamaki zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT lequynhanh zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT linqingyi zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT takebayashikoki zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT yoshimuranaoaki zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT taniharafuminori zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT thongkittidilokchommanart zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT otoitakeshige zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes